Jiayi Shen

Jiayi Shen

Auto-generated profile, based on publicly available information

Jiayi Shen

Department of Population and Public Health Sciences, Division of Biostatistics, Keck School of Medicine University of Southern California Los Angeles California USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2023 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
AWAnqi Wang
Anqi Wang
JSJiayi Shen
Jiayi Shen
ARAlex A. Rodriguez
Alex A. Rodriguez
ESEdward J. Saunders
Edward J. Saunders
FCFei Chen
Fei Chen
CHChristopher A. Haiman
Christopher A. Haiman

27 May 2026 in Cancer Epidemiology, Biomarkers & Prevention
Verified
Journal Article
Open access
DBDavid Bogumil
David Bogumil
XSXin Sheng
Xin Sheng
PWPeggy Wan
Peggy Wan
LXLucy Xia
Lucy Xia
LPLoreall Pooler
Loreall Pooler
DCDavid V. Conti
David V. Conti
Background: The Multiethnic Cohort Study (MEC) is a US prospective cohort of more than 215,000 participants, designed to investigate variation in risk factors and disease across diverse racial and ethnic groups. More than 74,000 participants contributed biospecimens for genetic studies. We describe this subcohort and demonstrate the types of analyses it enables. Methods: The MEC recruited adults aged 45 to 75 in California and Hawaii between 1993 and 1996. Cancer diagnoses were identified via state tumor registries. The MEC Genetics Database includes 73,139 participants with germline genotype data. We evaluated genetic similarity, its relationship with self-reported race/ethnicity, and baseline characteristics, including neighborhood socioeconomic status (nSES). Using breast, colorectal, and prostate cancer as examples, we conducted genome-wide association studies (GWAS), assessed nongenetic risk factors, and performed time-to-event analyses. Results: Participants included 10,962 African Americans, 24,234 Japanese Americans, 17,242 Latinos, 5,488 Native Hawaiians, 14,649 Whites, and 564 others. Principal component analysis showed substantial diversity. Multiethnic GWAS replicated known variants with effective control of population stratification. Polygenic risk score (PRS) effects varied across groups. Time-to-event models revealed associations between cancer incidence and nSES, population descriptors, and genetic similarity. Conclusions: The MEC Genetics Database enables multiancestry analyses of genetic and nongenetic cancer risk, supporting research on disparities, polygenic traits, and integrated risk prediction. Impact: Example analyses using these resources show the relationship between population descriptors, PRSs, and common cancer risk factors that require special consideration in genetic analyses.

22 December 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
JSJiayi Shen
Jiayi Shen
LJLai Jiang
Lai Jiang
KWKan Wang
Kan Wang
AWAnqi Wang
Anqi Wang
FCFei Chen
Fei Chen
DCDavid V. Conti
David V. Conti
Recent advancement in Genome-wide Association Studies (GWAS) comes from not only increasingly larger sample sizes but also the shifted focus towards underrepresented populations. Multi-population GWAS may increase power to detect novel risk variants and improve fine-mapping resolution by leveraging evidence from diverse populations and accounting for the difference in linkage disequilibrium (LD) across ethnic groups. Here, we expand upon our previous approach for single-population fine-mapping through Joint Analysis of Marginal SNP Effects (JAM) to a multi-population analysis (mJAM). Under the assumption that true causal variants are common across studies, we implement a novel version of JAM that conditions on multiple SNPs while explicitly incorporating the different LD structures across populations. The mJAM framework can be used to first select index variants using the mJAM likelihood with any feature selection approach. In addition, we present a novel approach leveraging the ideas of mediation to construct credible sets for these index variants. Construction of such credible sets can be performed given any existing index variants. We illustrate the implementation of the mJAM likelihood through two implementations: mJAM-SuSiE (a Bayesian approach) and mJAM-Forward selection. Through simulation studies based on realistic effect sizes and levels of LD, we demonstrated that mJAM performs better than other existing multi-ethnic methods for constructing concise credible sets that include the underlying causal variants. In real data examples taken from the most recent multi-population prostate cancer GWAS, we showed several practical advantages of mJAM over other existing methods.

12 April 2024 in Genetic Epidemiology
Verified
Journal Article
Open access
JSJiayi Shen
Jiayi Shen
LJLai Jiang
Lai Jiang
KWKan Wang
Kan Wang
AWAnqi Wang
Anqi Wang
FCFei Chen
Fei Chen
DCDavid V. Conti
David V. Conti
Recent advancement in genome‐wide association studies (GWAS) comes from not only increasingly larger sample sizes but also the shift in focus towards underrepresented populations. Multipopulation GWAS increase power to detect novel risk variants and improve fine‐mapping resolution by leveraging evidence and differences in linkage disequilibrium (LD) from diverse populations. Here, we expand upon our previous approach for single‐population fine‐mapping through Joint Analysis of Marginal SNP Effects (JAM) to a multipopulation analysis (mJAM). Under the assumption that true causal variants are common across studies, we implement a hierarchical model framework that conditions on multiple SNPs while explicitly incorporating the different LD structures across populations. The mJAM framework can be used to first select index variants using the mJAM likelihood with different feature selection approaches. In addition, we present a novel approach leveraging the ideas of mediation to construct credible sets for these index variants. Construction of such credible sets can be performed given any existing index variants. We illustrate the implementation of the mJAM likelihood through two implementations: mJAM‐SuSiE (a Bayesian approach) and mJAM‐Forward selection. Through simulation studies based on realistic effect sizes and levels of LD, we demonstrated that mJAM performs well for constructing concise credible sets that include the underlying causal variants. In real data examples taken from the most recent multipopulation prostate cancer GWAS, we showed several practical advantages of mJAM over other existing multipopulation methods.


17 June 2024 in Genetic Epidemiology
Verified
Journal Article
Open access
LJLai Jiang
Lai Jiang
JSJiayi Shen
Jiayi Shen
BDBurcu F. Darst
Burcu F. Darst
CHChristopher A. Haiman
Christopher A. Haiman
NMNicholas Mancuso
Nicholas Mancuso
DCDavid V. Conti
David V. Conti
Instrumental variable (IV) analysis has been widely applied in epidemiology to infer causal relationships using observational data. Genetic variants can also be viewed as valid IVs in Mendelian randomization and transcriptome‐wide association studies. However, most multivariate IV approaches cannot scale to high‐throughput experimental data. Here, we leverage the flexibility of our previous work, a hierarchical model that jointly analyzes marginal summary statistics (hJAM), to a scalable framework (SHA‐JAM) that can be applied to a large number of intermediates and a large number of correlated genetic variants—situations often encountered in modern experiments leveraging omic technologies. SHA‐JAM aims to estimate the conditional effect for high‐dimensional risk factors on an outcome by incorporating estimates from association analyses of single‐nucleotide polymorphism (SNP)‐intermediate or SNP‐gene expression as prior information in a hierarchical model. Results from extensive simulation studies demonstrate that SHA‐JAM yields a higher area under the receiver operating characteristics curve (AUC), a lower mean‐squared error of the estimates, and a much faster computation speed, compared to an existing approach for similar analyses. In two applied examples for prostate cancer, we investigated metabolite and transcriptome associations, respectively, using summary statistics from a GWAS for prostate cancer with more than 140,000 men and high dimensional publicly available summary data for metabolites and transcriptomes.